Predictability of Distalization and Derotation of the Carriere Motion Appliance.
Launched by UNIVERSITY OF SALAMANCA · Oct 25, 2021
Trial Information
Current as of July 04, 2025
Completed
Keywords
ClinConnect Summary
15 patients with Class II molar and canine relationship were submitted to orthodontic treatment with CMA. All patients were exposed preoperatively (STL1) and postoperatively (STL2) to a digital impression and afterwards were uploaded into a specific cephalometric software to allow the automatic mesh networks alignment of the STL digital files. Subsequently, the distal tooth displacement of upper canines and first upper molars and also the derotation angle of first upper molars were measured. The repeatability and reproducibility were analyzed by Gage R\&R statistical analysis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Growing patients
- • Late mixed dentition or permanent dentition
- • Fully erupted definitive molars
- • No history of previous orthodontic treatment
- • Complete pre- and post-treatment records (digital study models)
- • Dental Class II relationship.
- Exclusion Criteria:
- • Permanent dentition
- • Adults
- • Dental Class I, III
About University Of Salamanca
The University of Salamanca, one of the oldest and most prestigious universities in Spain, is a leading institution in academic research and clinical trials. With a strong commitment to advancing healthcare and medical science, the university engages in innovative research initiatives that address critical health challenges. Its clinical trial programs are characterized by rigorous scientific methodology, interdisciplinary collaboration, and a focus on ethical standards, ensuring high-quality outcomes that contribute to the advancement of medical knowledge and patient care. The University of Salamanca fosters partnerships with healthcare professionals and industry leaders, positioning itself at the forefront of clinical research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salamanca, Castilla Leon, Spain
Patients applied
Trial Officials
Aldara Nercellas Rodríguez
Principal Investigator
University of Salamanca
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials